The Effect of the Mobile Application Developed for Home Care of Preterm

The Effect of the Mobile Application Developed for Home Care of the Premature Baby on the Mother's Baby Care Skills, Self-efficacy and Mother-infant Bonding

mobile application will be developed to support the post-discharge home care of mothers of premature babies. With the developed mobile application, the effect of the education given to the mothers on the knowledge and skills of infant care, mother-infant attachment, and the mother's self-efficacy will be evaluated.

Study Overview

• Status: Not yet recruiting
• Conditions: Education; Premature; Mobile Application; Home Care; Mother
• Intervention / Treatment: Other: education with mobile application

Detailed Description

This research aims to examine the effect of the mobile application developed for the home care of the babies of the mothers of premature babies on their baby care knowledge and skills, mother-infant attachment and mother self-efficacy. A mobile application will be developed to support mothers who care for their premature babies at home after discharge. The application will be installed on the phones of mothers whose babies are discharged from the neonatal intensive care unit. After the babies are discharged, mothers will be trained at home with a mobile application. Maternal self-efficacy and mother-infant supplementation will be measured when infants admitted the NICU and one month after discharge the NICU.

• Study Type: Interventional
• Enrollment (Anticipated): 48
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

For mothers;

• Being over the age of 18,
• Having a premature baby
• At least primary school graduate,
• Smart mobile app can be installed have a phone,
• Being able to understand and speak Turkish,
• Residing in Ankara

For babies;

• 32-37 weeks of gestation of the baby (middle and borderline premature)
• Baby in neonatal intensive care unit to stay
• Not having undergone a surgical operation,
• Absence of physical anomalies

Exclusion Criteria:

For Mothers;

• Diagnosed with postpartum depression
• unwillingness to participate in the study

For babies;

- Very small preterm (born below 28 weeks of gestation) and small preterm (between 28 and 31 weeks of gestation)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: providing training to mothers of premature babies with a mobile application; providing training with mobile application to mothers discharged home with their premature babies +standard education prior to discharge	Other: education with mobile application; providing training to mothers of premature babies with a mobile application
No Intervention: standard education prior to discharge control group; standard education prior to discharge; standard education prior to discharge

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
parent self-efficacy scale	scale that measures mother's self-efficacy for baby care.The unabridged name of the scale is parent self-efficacy scale. The lowest score obtained from the scale is 18, the highest score is 90. low score indicates high self-efficacy	up to 10 months
parent self-efficacy scale	scale that measures mother's self-efficacy for baby care.The unabridged name of the scale is parent self-efficacy scale. The lowest score obtained from the scale is 18, the highest score is 90. low score indicates high self-efficacy.	up to 14 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
maternal attachment scale	scale that measuring mother-infant attachment. The unabridged name of the scale is maternal attachment scale. The lowest score obtained from the scale is 26, the highest score is 104. A high score indicates high maternal attachment.	up to 10 months
maternal attachment scale	scale that measuring mother-infant attachment. The unabridged name of the scale is maternal attachment scale. The lowest score obtained from the scale is 26, the highest score is 104. A high score indicates high maternal attachment.	up to 14 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
baby care knowledge and skills form	Form that measuring baby care knowledge and skills. The unabridged name of the form is baby care knowledge and skills form. Since the form created by the researcher has not been finalized, the lowest and highest scores to be obtained from the form are not certain. A high score indicates a high level of knowledge and skill of the mother.	up to 14 months

Collaborators and Investigators

• Sponsor: Ankara University

Study record dates

Study Major Dates

• Study Start (Anticipated): December 16, 2022
• Primary Completion (Anticipated): August 30, 2023
• Study Completion (Anticipated): December 30, 2023

Study Registration Dates

• First Submitted: June 22, 2022
• First Submitted That Met QC Criteria: June 24, 2022
• First Posted (Actual): June 29, 2022

Study Record Updates

• Last Update Posted (Actual): July 1, 2022
• Last Update Submitted That Met QC Criteria: June 28, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Keywords: Mothers, premature, mobile application, education, home care
• Additional Relevant MeSH Terms: Pregnancy Complications; Obstetric Labor Complications; Obstetric Labor, Premature; Premature Birth
• Other Study ID Numbers: AnkaraU06GKY

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: When the study is completed and published, the score obtained from the parent self-efficacy scale and maternal attachment scale will be shared.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No